Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | POLB | P06746 | 2/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | MMP9 | P14780 | 1/20 | 0.54 |
| ▸ | MMP8 | P22894 | 1/20 | 0.54 |
| ▸ | MMP13 | P45452 | 1/20 | 0.54 |
| ▸ | PLA2G4B | P0C869 | 3/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31558760 | 0.97 | LMNA (0.62) | LMNAPOLBTP53TSHRMMP9 | |
| SCHEMBL9191267 | 0.95 | LMNA (0.64) | LMNAPOLBTP53TSHRMMP9 | |
| SCHEMBL9193732 | 0.95 | LMNA (0.64) | LMNAPOLBTP53TSHRMMP9 | |
| SCHEMBL9194774 | 0.95 | LMNA (0.64) | LMNAPOLBTP53TSHRMMP9 | |
| SCHEMBL9189425 | 0.95 | LMNA (0.64) | LMNAPOLBTP53TSHRMMP9 | |
| SCHEMBL3685459 | 0.93 | L3MBTL1 (0.53) | LMNAPOLBSMN1; SMN2TDP1L3MBTL1 | |
| SCHEMBL8323514 | 0.93 | L3MBTL1 (0.53) | LMNAPOLBSMN1; SMN2TDP1L3MBTL1 | |
| SCHEMBL9380908 | 0.92 | RARB (0.59) | LMNAPOLBTP53TSHRMAPK1 | |
| SCHEMBL9380903 | 0.92 | RARB (0.59) | LMNAPOLBTP53TSHRMAPK1 | |
| SCHEMBL9386812 | 0.87 | TDP1 (0.48) | LMNAPOLBMAPK1SMN1; SMN2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120005420-A | Disperse dye for superfine denier fiber and synthesis method thereof | 青岛大学 | 2025-05-16 | — | — | CN | disclosed |
| US-7737286-B2 | α-Hydroxy-benzeneacetic acid derivatives, and compounds having two 5-membered latone rings fused to central cyclohexa-1,4-diene nucleus based upon the same, and uses of the compounds | KYUNG-IN SYNTHETIC CORPORATION (KR) | 2010-06-15 | — | — | US | disclosed |
| EP-1663934-A4 | ALPHA-HYDROXY-BENZENEACETIC ACID DERIVATIVES, AND COMPOUNDS HAVING TWO 5-MEMBERED LACTONE RINGS FUSED TO CENTRAL CYCLOHEXA-1,4-DIENE NUCLEUS BASED UPON THE SAME, AND USES OF THE COMPOUNDS | KYUNG IN SYNTHETIC CORP (KR) | 2008-10-01 | — | — | EP | disclosed |
| US-20070220688-A1 | Alpha-Hydroxy-Benzeneacetic Acid Derivatives, and Compounds Having Two 5-Membered Latone Rings Fused to Central Cyclohexa-1,4-Diene Nucleus Based Upon the Same, and Uses of the Compounds | KYUNG-IN SYNTHETIC CORPORATION (KR) | 2007-09-27 | — | — | US | disclosed |
| EP-1663934-A1 | ALPHA-HYDROXY-BENZENEACETIC ACID DERIVATIVES, AND COMPOUNDS HAVING TWO 5-MEMBERED LACTONE RINGS FUSED TO CENTRAL CYCLOHEXA-1,4-DIENE NUCLEUS BASED UPON THE SAME, AND USES OF THE COMPOUNDS | KYUNG-IN SYNTHETIC CORPORATION (KR) | 2006-06-07 | — | — | EP | disclosed |
| WO-2005028409-A1 | ALPHA-HYDROXY-BENZENEACETIC ACID DERIVATIVES, AND COMPOUNDS HAVING TWO 5-MEMBERED LACTONE RINGS FUSED TO CENTRAL CYCLOHEXA-1,4-DIENE NUCLEUS BASED UPON THE SAME, AND USES OF THE COMPOUNDS | KYUNG-IN SYNTHETIC CORPORATION (KR) | 2005-03-31 | — | — | WO | disclosed |
| EP-0545861-B1 | Diphenylacetic acid derivatives as stabilisers for organic material | CIBA GEIGY AG (CH) | 1995-12-27 | — | — | EP | disclosed |
| EP-0545861-A2 | Diphenylacetic acid derivatives as stabilisers for organic material | CIBA-GEIGY AG (CH) | 1993-06-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070220688-A1 | Alpha-Hydroxy-Benzeneacetic Acid Derivatives, and Compounds Having Two 5-Membered Latone Rings Fused to Central Cyclohexa-1,4-Diene Nucleus Based Upon the Same, and Uses of the Compounds | LDHA, HCAR1, HPD | LMNA 79/4885POLB 2441/4885TP53 1854/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.